Stay updated on CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Sign up to get notified when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.

Latest updates to the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page
- ChecktodayChange DetectedThe page now displays a 403 Forbidden error with the standard 403 layout, replacing the study content. This indicates restricted access to the NCT03504488 record.SummaryDifference18%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision tag 'Revision: v3.6.6' was added, and the previous 'Revision: v3.6.5' tag was removed. The change updates the page's revision metadata rather than its substantive content.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new build of the page.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.6.4 is now displayed, replacing the previous Revision: v3.6.3. This reflects a metadata/version update on the page rather than a substantive change to the study details.SummaryDifference0.0%

- Check79 days agoChange DetectedThe revision tag on the page was updated from v3.6.2 to v3.6.3, marking a new version of the page.SummaryDifference0.0%

- Check86 days agoChange DetectedA new revision tag, v3.6.2, was added and the previous tag v3.6.0 was removed. This represents a metadata version update on the page rather than a change to study content.SummaryDifference0.0%

Stay in the know with updates to CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.